Cymbalta Approved for Pediatric Patients With Fibromyalgia
The Food and Drug Administration (FDA) has expanded the approval of Cymbalta (duloxetine; Lilly) to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.
Diagnosis & Disease Information
AMA Releases Recommendations for Opioid Use Disorder, Pain During COVID-19
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
Many Legal Marijuana Products Too Strong for Treating Pain
Legally dispensed marijuana products have stronger concentrations of THC and CBD than needed for chronic pain relief.
Can Alternative Pain Management Reduce Opioid Dependence?
Managing moderate or severe postoperative pain, which affects 75% of patients in the United States, remains a challenge for physicians.
Telementoring Shows Promise in Opioid Management
The project, which began in New Mexico in 2003, uses videoconferencing to connect remote physicians to specialists who provide mentorship and insight into specific disease states.
The Link Between Opioid Receptor Function and Ethnic Disparities in Pain Management
Using μ-opioid imaging outcomes, researchers examined differences in BPND; [11C]carfentanil among healthy adults identifying as non-Hispanic black and non-Hispanic white.
Navigating Patient Pain Under Stricter Opioid Prescribing Laws
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
Closed-Loop Spinal Cord Stimulation for the Management of Chronic Back and Leg Pain
Spinal cord stimulation (SCS) with a closed-loop system that uses recorded evoked compound action potentials (ECAPs) is superior to a fixed-output, open-loop system for patients with chronic back and leg pain.
Ubrogepant Works Quickly to Relieve Acute Migraine Pain
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.
Most Patients With Opioid-Related Hospitalizations Have Chronic Conditions
Since patients with chronic diseases are often prescribed opioids, researchers sought to examine the association between opioid-related hospitalization and patients with chronic disease. Since patients with chronic diseases are often prescribed opioids, researchers sought to examine the association between opioid-related hospitalization and patients with chronic disease.
- Loading...
Loading...
Next post in News
Loading... 
Loading...